Oxygenta Pharmaceutical Ltd

NSE: SSORGS · BSE: 524636 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹48.17
Market cap: ₹178.2 Cr
Revenue (annual): ₹113.0 Cr
Net profit (annual): ₹-17.57 Cr
P/E (TTM): -13.1×Sector 47.4×
Promoter holding: 56.54%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Annual General Meeting 2 Financial Results 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

27 Jul 2026 18:21 IST BSE

Other Announcement

Oxygenta Pharmaceutical Other Announcement

Oxygenta Pharmaceutical Limited has appointed M/s. PCR & Associates as its Cost Auditor for a 12-month term. This appointment follows the company's recent board meeting.

Read the filing ↗

18 Jul 2026 10:33 IST BSE

Other Announcement

Oxygenta Pharmaceutical Other Announcement

Oxygenta Pharmaceutical Ltd submitted its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulatory requirements.

Read the filing ↗